Guru Ownership Trend
Guru Analysis for Kalaris Therapeutics, Inc. (KLRS)
Kalaris Therapeutics, Inc. (KLRS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $325,462.92.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $124,631.91 net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 24.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Kalaris Therapeutics, Inc. (KLRS)
Major holders include Renaissance Technologies (RenTech) ($381,691). According to the latest reported data, 1 tracked investment managers collectively hold approximately 66,151 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $124,631.91, with 0 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KLRS. The total reported sell value was $124,631.91.
No tracked managers opened new positions or increased their holdings in KLRS during the most recent reporting period.